What is the dosing recommendation for Florastor (Saccharomyces boulardii)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Florastor (Saccharomyces boulardii) Dosing Recommendations

The standard dosing for Florastor (Saccharomyces boulardii) is 250-500 mg twice daily, with specific dosing regimens depending on the clinical indication. 1

General Dosing Guidelines

  • For adults and children 12 years and over: 250 mg (1 capsule) twice daily 2
  • For prevention of antibiotic-associated diarrhea: 250-500 mg twice daily for the duration of antibiotic therapy and 1 week after completion 1
  • For treatment of recurrent Clostridioides difficile infection: 500 mg twice daily (1 g/day) for 4 weeks as an adjunct to standard antibiotic therapy 1
  • For acute diarrhea in children: 250 mg twice daily (5 billion CFU twice daily) for 5 days 3

Specific Clinical Scenarios

Prevention of Antibiotic-Associated Diarrhea

  • Start Saccharomyces boulardii within 48 hours of beginning antibiotic therapy 4
  • Continue treatment throughout antibiotic course and for 7 days after antibiotic withdrawal 4
  • Dosage: 250-500 mg twice daily 1

Recurrent C. difficile Infection

  • Most effective when combined with high-dose vancomycin (2 g/day) 1
  • Dosage: 500 mg twice daily (1 g/day total) for 4 weeks 1
  • Less effective when combined with lower-dose vancomycin (500 mg/day) or metronidazole 1

Inflammatory Bowel Disease

  • Dosage: 250 mg three times daily for 4 weeks 5
  • May be used as adjunctive therapy with standard treatments 5

Special Populations

  • Children under 12 years: Consult a physician before use 2
  • Infants (3-36 months) with acute diarrhea: 5 billion CFU twice daily for 5 days 3
  • Immunocompromised patients: Saccharomyces boulardii is contraindicated due to risk of fungemia 1
  • Critically ill patients: Avoid use due to reported cases of fungemia 1

Safety Considerations

  • Saccharomyces boulardii has been associated with fungemia in critically ill and immunocompromised patients 1
  • Do not administer to patients at risk of bacteremia or fungemia 1
  • Generally considered safe for the general population by regulatory authorities 1
  • Careful evaluation is required before use in patients with damaged intestinal mucosa or immune dysregulation 1

Administration Tips

  • Can be taken with or without food 2
  • Capsules can be opened and mixed with cool foods or liquids for patients who cannot swallow pills 2
  • Do not mix with hot beverages or foods as heat may inactivate the yeast 2
  • Store at room temperature in a dry place 2

Remember that Saccharomyces boulardii is a living organism and its efficacy depends on maintaining viability until it reaches the intestines. The risk-benefit ratio should be carefully considered, particularly in vulnerable populations.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.